GSK Execs Copped To Bribery, Tax Crimes, China Says

Law360, New York (July 11, 2013, 12:15 PM ET) -- Chinese officials said Thursday that U.K. drugmaker GlaxoSmithKline PLC executives had confessed to commercial bribery and tax-related crimes, allegedly paying physicians and hospitals to bolster drug sales. 

The charges, which come just a week after Chinese authorities detained a number of GSK employees over unspecified “economic crimes,” are part of long-running “serious economic crime,” China’s Public Security Bureau said on its website Thursday. Officials have not provided details on the scale and length of the alleged crimes, but say that some GSK executives have been arrested on...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers